Racial discrepancies in the outcome of patients with hepatocellular carcinoma

Lawrence E. Harrison, Trevor Reichman, Baburao Koneru, Adrian Fisher, Dorian Wilson, Andrew Dela Torre, Arun Samanta, Maria Korogodsky

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Hypothesis: There is a marked variation in the outcome of patients with hepatocellular carcinoma with respect to race and ethnicity. Rates among African American and Hispanic individuals are elevated as compared with those among white individuals. Designs: Retrospective review of a prospective database. Demographic information, clinical staging, and other defining factors, including the absence or presence of hepatitis, cirrhosis, and alcohol abuse, were analyzed by patient interviews and review of the medical record. Setting: Urban tertiary referral teaching hospital. Patients: Patients diagnosed as having hepatocellular carcinoma between July 1997 and June 2003 (N = 264). Main Outcome Measure: Overall survival rates. Results: Based on multivariate analysis, race was identified as an independent predictor of survival. While there was no difference in the distribution of patient or tumor characteristics between the 2 groups, African American/Hispanic patients had a 5-year survival rate of 12%, which was significantly lower than that of white patients (50%; P = .O01). Conclusions: This study demonstrates a significant discrepancy in overall survival of African American/Hispanic patients as compared with that of white patients. The reason for this difference cannot be explained by patient or tumor characteristics or completely by treatment allocation. These data suggest that there may be socioeconomic, biological, and/or cultural determinants contributing to this observed difference in outcome.

Original languageEnglish (US)
Pages (from-to)992-996
Number of pages5
JournalArchives of Surgery
Volume139
Issue number9
DOIs
StatePublished - Sep 1 2004
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
Hispanic Americans
African Americans
Survival Rate
Survival
Tertiary Care Centers
Teaching Hospitals
Hepatitis
Alcoholism
Medical Records
Neoplasms
Fibrosis
Multivariate Analysis
Demography
Outcome Assessment (Health Care)
Databases
Interviews

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Harrison, L. E., Reichman, T., Koneru, B., Fisher, A., Wilson, D., Dela Torre, A., ... Korogodsky, M. (2004). Racial discrepancies in the outcome of patients with hepatocellular carcinoma. Archives of Surgery, 139(9), 992-996. https://doi.org/10.1001/archsurg.139.9.992
Harrison, Lawrence E. ; Reichman, Trevor ; Koneru, Baburao ; Fisher, Adrian ; Wilson, Dorian ; Dela Torre, Andrew ; Samanta, Arun ; Korogodsky, Maria. / Racial discrepancies in the outcome of patients with hepatocellular carcinoma. In: Archives of Surgery. 2004 ; Vol. 139, No. 9. pp. 992-996.
@article{6f0c8b560d6548329d27fe038f26059d,
title = "Racial discrepancies in the outcome of patients with hepatocellular carcinoma",
abstract = "Hypothesis: There is a marked variation in the outcome of patients with hepatocellular carcinoma with respect to race and ethnicity. Rates among African American and Hispanic individuals are elevated as compared with those among white individuals. Designs: Retrospective review of a prospective database. Demographic information, clinical staging, and other defining factors, including the absence or presence of hepatitis, cirrhosis, and alcohol abuse, were analyzed by patient interviews and review of the medical record. Setting: Urban tertiary referral teaching hospital. Patients: Patients diagnosed as having hepatocellular carcinoma between July 1997 and June 2003 (N = 264). Main Outcome Measure: Overall survival rates. Results: Based on multivariate analysis, race was identified as an independent predictor of survival. While there was no difference in the distribution of patient or tumor characteristics between the 2 groups, African American/Hispanic patients had a 5-year survival rate of 12{\%}, which was significantly lower than that of white patients (50{\%}; P = .O01). Conclusions: This study demonstrates a significant discrepancy in overall survival of African American/Hispanic patients as compared with that of white patients. The reason for this difference cannot be explained by patient or tumor characteristics or completely by treatment allocation. These data suggest that there may be socioeconomic, biological, and/or cultural determinants contributing to this observed difference in outcome.",
author = "Harrison, {Lawrence E.} and Trevor Reichman and Baburao Koneru and Adrian Fisher and Dorian Wilson and {Dela Torre}, Andrew and Arun Samanta and Maria Korogodsky",
year = "2004",
month = "9",
day = "1",
doi = "10.1001/archsurg.139.9.992",
language = "English (US)",
volume = "139",
pages = "992--996",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "9",

}

Harrison, LE, Reichman, T, Koneru, B, Fisher, A, Wilson, D, Dela Torre, A, Samanta, A & Korogodsky, M 2004, 'Racial discrepancies in the outcome of patients with hepatocellular carcinoma', Archives of Surgery, vol. 139, no. 9, pp. 992-996. https://doi.org/10.1001/archsurg.139.9.992

Racial discrepancies in the outcome of patients with hepatocellular carcinoma. / Harrison, Lawrence E.; Reichman, Trevor; Koneru, Baburao; Fisher, Adrian; Wilson, Dorian; Dela Torre, Andrew; Samanta, Arun; Korogodsky, Maria.

In: Archives of Surgery, Vol. 139, No. 9, 01.09.2004, p. 992-996.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Racial discrepancies in the outcome of patients with hepatocellular carcinoma

AU - Harrison, Lawrence E.

AU - Reichman, Trevor

AU - Koneru, Baburao

AU - Fisher, Adrian

AU - Wilson, Dorian

AU - Dela Torre, Andrew

AU - Samanta, Arun

AU - Korogodsky, Maria

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Hypothesis: There is a marked variation in the outcome of patients with hepatocellular carcinoma with respect to race and ethnicity. Rates among African American and Hispanic individuals are elevated as compared with those among white individuals. Designs: Retrospective review of a prospective database. Demographic information, clinical staging, and other defining factors, including the absence or presence of hepatitis, cirrhosis, and alcohol abuse, were analyzed by patient interviews and review of the medical record. Setting: Urban tertiary referral teaching hospital. Patients: Patients diagnosed as having hepatocellular carcinoma between July 1997 and June 2003 (N = 264). Main Outcome Measure: Overall survival rates. Results: Based on multivariate analysis, race was identified as an independent predictor of survival. While there was no difference in the distribution of patient or tumor characteristics between the 2 groups, African American/Hispanic patients had a 5-year survival rate of 12%, which was significantly lower than that of white patients (50%; P = .O01). Conclusions: This study demonstrates a significant discrepancy in overall survival of African American/Hispanic patients as compared with that of white patients. The reason for this difference cannot be explained by patient or tumor characteristics or completely by treatment allocation. These data suggest that there may be socioeconomic, biological, and/or cultural determinants contributing to this observed difference in outcome.

AB - Hypothesis: There is a marked variation in the outcome of patients with hepatocellular carcinoma with respect to race and ethnicity. Rates among African American and Hispanic individuals are elevated as compared with those among white individuals. Designs: Retrospective review of a prospective database. Demographic information, clinical staging, and other defining factors, including the absence or presence of hepatitis, cirrhosis, and alcohol abuse, were analyzed by patient interviews and review of the medical record. Setting: Urban tertiary referral teaching hospital. Patients: Patients diagnosed as having hepatocellular carcinoma between July 1997 and June 2003 (N = 264). Main Outcome Measure: Overall survival rates. Results: Based on multivariate analysis, race was identified as an independent predictor of survival. While there was no difference in the distribution of patient or tumor characteristics between the 2 groups, African American/Hispanic patients had a 5-year survival rate of 12%, which was significantly lower than that of white patients (50%; P = .O01). Conclusions: This study demonstrates a significant discrepancy in overall survival of African American/Hispanic patients as compared with that of white patients. The reason for this difference cannot be explained by patient or tumor characteristics or completely by treatment allocation. These data suggest that there may be socioeconomic, biological, and/or cultural determinants contributing to this observed difference in outcome.

UR - http://www.scopus.com/inward/record.url?scp=4444309365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444309365&partnerID=8YFLogxK

U2 - 10.1001/archsurg.139.9.992

DO - 10.1001/archsurg.139.9.992

M3 - Review article

C2 - 15381619

AN - SCOPUS:4444309365

VL - 139

SP - 992

EP - 996

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 9

ER -